Mecapegfilgrastim for prophylaxis of febrile neutropenia in children and adolescents with rhabdomyosarcoma or Ewing sarcoma: a prospective, single-arm, pilot study

Abstract Background The chemotherapy regimens recommended for both rhabdomyosarcoma (RMS) and Ewing sarcoma (ES) patients are myelosuppressive and can reduce the absolute neutrophil count (ANC) and subsequently increase the risk of febrile neutropenia (FN). However, only a few studies have focused o...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wen Zhao, Yuchen Zhou, Xisi Wang, Peiyi Yang, Cheng Huang, Xiaoli Ma, Yan Su, Rui Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-08-01
coleção:	BMC Cancer
Assuntos:	Rhabdomyosarcoma Ewing sarcoma Febrile neutropenia Granulocyte colony-stimulating factor Pegfilgrastim
Acesso em linha:	https://doi.org/10.1186/s12885-024-12766-w
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!